Abstract
We utilized a cDNA expression library derived from the B6SutA1 mouse myeloid progenitor cell line to search for novel oncogenes that promote growth transformation of NIH3T3 cells. A 2.2 kb transforming cDNA was recovered that encodes the wild type thrombin-stimulated G protein-coupled receptor PAR-1. In addition to its potent focus forming activity, constitutive overexpression of PAR-1 in NIH3T3 cells promoted the loss of anchorage- and serum-dependent growth. Although inhibitors of thrombin failed to block PAR-1 transforming activity, a PAR-1 mutant that cannot be cleaved by thrombin was nontransforming. Since the foci of transformed cells induced by PAR-1 bear a striking resemblance to those induced by activated RhoA, we determined if PAR-1 transformation was due to the aberrant activation of a specific Rho family member. Like RhoA, PAR-1 cooperated with activated Raf-1 and caused synergistic enhancement of transforming activity, induced stress fibers when microinjected into porcine aortic endothelial cells, stimulated the activity of the serum response factor and NF-κB transcription factors, and PAR-1 transformation was blocked by co-expression of dominant negative RhoA. Finally, PAR-1 transforming activity was blocked by pertussis toxin and by co-expression of the RGS domain of Lsc, implicating Gαi and Gα12/Gα13 subunits, respectively, as mediators of PAR-1 transformation. Taken together, these observations suggest that PAR-1 growth transformation is mediated, in part, by activation of RhoA.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Allen LF, Lefkowitz RJ, Caron MG, Cotecchia S . 1991 Proc. Natl. Acad. Sci. USA 88: 11354–11358
Betuing S, Daviaud D, Pages C, Bonnard E, Valet P, Lafontan M, Saulnier-Blache JS . 1998 J. Biol. Chem. 273: 15804–15810
Bourne HR, Sanders DA, McCormick F . 1990 Nature 348: 125–132
Camerer E, Huang W, Coughlin R . 2000 Proc. Natl. Acad. Sci. USA 97: 5255–5260
Chan AML, Fleming TP, McGovern ES, Chedid M, Miki T, Aaronson SA . 1993 Mol. Cell. Biol. 13: 762–768
Clark GJ, Cox AD, Graham SM, Der CJ . 1995 Methods Enzymol. 255: 395–412
Coso OA, Chiarello M, Yu J-C, Teramoto H, Crespo P, Xu N, Miki T . 1995 Cell 81: 1137–1146
Coughlin SR . 1993 Thromb. Haemos. 66: 184–187
De Vivo M, Chen J, Codina J, Iyengar R . 1992 J. Biol. Chem. 267: 18263–18266
Dery O, Corvera CU, Steinhoff M, Bunnett NW . 1998 Am. J. Physiol. 274: C1429–C1452
Dhanasekaran N, Heasley LE, Johnson GL . 1995 Endocrine Rev. 16: 259–270
Dhanasekaran N, Tsim ST, Dermott JM, Onesime D . 1998 Oncogene 17: 1383–1394
Even-Ram S, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M, Ginzburg Y, Reich R, Vlodavsky I, Bar-Shavit R . 1998 Nat. Med. 4: 909–914
Fareed J, Lewis BE, Callas DD, Hoppensteadt DA, Walenga JM, Bick RL . 1999 Clin. Appl. Thromb. Hemost. 5: S45–S55
Feig LA . 1999 Nat. Cell Biol. 1: E25–E27
Genda T, Sakamoto M, Ichida T, Asakura H, Kojiro M, Narumiya S, Hirohashi S . 1999 Hepatology 30: 1027–1036
Gupta SK, Gallego C, Johnson GL, Heasley LE . 1992 J. Biol. Chem. 267: 7987–7990
Gutkind JS . 1998 J. Biol. Chem. 273: 1839–1842
Gutkind JS, Novotny EA, Brann MR, Robbins KC . 1991 Proc. Natl. Acad. Sci. USA 88: 4703–4707
Hart MJ, Sharma S, el-Masry N, Qui R-G, McCabe P, Polakis P, Bollag G . 1996 J. Biol. Chem. 271: 25452–25458
Hart MJ, Jiang X, Kozasa T, Roscoe W, Singer WD, Gilman AG, Sternweis PC, Bollag G . 1998 Science 280: 2112–2114
Henrikson KP, Salazar SL, Fenton JW, Pentecost BT . 1999 Br. J. Cancer 79: 401–406
Hill CS, Wynne J, Treisman R . 1995 Cell 81: 1159–1170
Jiang H, Wu D, Simon MI . 1993 FEBS Lett. 330: 319–322
Julius D, Livelli TJ, Jessell TM, Axel R . 1989 Science 244: 1057–1062
Kalinec G, Nazarali AJ, Hermouet S, Xu N, Gutkind JS . 1992 Mol. Cell. Biol. 12: 4687–4693
Khosravi-Far R, Solski PA, Kinch MS, Burridge K, Der CJ . 1995 Mol. Cell. Biol. 15: 6443–6453
Khosravi-Far R, White MA, Westwick JK, Solski PA, Chrzanowska-Wodnicka M, Van Aelst L, Wigler MH, Der CJ . 1996 Mol. Cell. Biol. 16: 3923–3933
Kozasa T, Jiang X, Hart MJ, Sternweis PM, Singer WD, Gilman AG, Bollag G, Sternweis PG . 1998 Science 280: 2109–2111
Macey MG, Howells GL, Stone SR, Newland AC . 1996 Leukemia 10: 687–692
Minden A, Lin A, Claret F-X, Abo A, Karin M . 1995 Cell 81: 1147–1157
Montaner S, Perona R, Saniger L, Lacal JC . 1998 J. Biol. Chem. 273: 12779–12785
Nobes CD, Hall A . 1995 Cell 81: 53–62
Olson MF, Ashworth A, Hall A . 1995 Science 269: 1270–1272
Perona R, Montaner L, Saniger I, Sanchez-Perez R, Bravo R, Lacal JC . 1997 Genes Dev. 11: 463–475
Ridley AJ, Hall A . 1992 Cell 70: 389–399
Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A . 1992 Cell 70: 401–410
Seasholtz TM, Majumdar M, Brown JH . 1999 Mol. Pharmacol. 55: 949–956
Sulciner DJ, Irani K, Yu Z-X, Ferrans VJ, Goldschmidt-Clermont P, Finkel T . 1996 Mol. Cell Biol. 16: 7115–7121
Tordai A, Fenton JW, Andersen T, Gelfand EW . 1993 J. Immunol. 150: 4876–4886
Van Aelst L, D'Souza-Schorey C . 1997 Genes Dev. 11: 2295–2322
van Biesen T, Luttrell LM, Hawes BE, Lefkowitz RJ . 1996 Endocrine Rev. 17: 698–714
van Corven EJ, Hordjik PL, Medema RH, Bos JL, Moolenaar WH . 1993 Proc. Natl. Acad. Sci. USA 90: 1257–1261
Van Obberghen-Schilling E, Pouysségur J . 1993 Thromb. Haemo. 70: 163–167
Van Obberghen-Schilling E, Vouret-Craviari V, Chen Y-H, Grall D, Chambard JC, Pouysségur J . 1998 Thrombin and Its Receptor in Growth Control In Annals New York Academy of Sciences
Vara Prasad MV, Shore SK, Dhanasekaran N . 1994 Oncogene 9: 2425–2429
Voyno-Yasenetskaya TA, Pace AM, Bourne HR . 1994 Oncogene 9: 2559–2565
Vu TK, Hung DT, Wheaton VI, Coughlin SR . 1991 Cell 64: 1057–1068
Westwick JK, Lambert QT, Clark GJ, Symons M, Van Aelst L, Pestell RG, Der CJ . 1997 Mol. Cell Biol. 17: 1324–1335
Westwick JK, Lee RJ, Lambert QT, Symons M, Pestell RG, Der CJ, Whitehead IP . 1998 J. Biol. Chem. 273: 16739–16747
Whitehead IP, Abe K, Gorski JL, Der CJ . 1998 Mol. Cell Biol. 18: 4689–4697
Whitehead IP, Campbell S, Rossman KL, Der CJ . 1997 Biochem. Biophys. Acta 1332: F1–F23
Whitehead IP, Khosravi-Far R, Kirk H, Trigo-Gonzalez G, Der CJ, Kay R . 1996 J. Biol. Chem. 271: 18643–18650
Whitehead IP, Kirk H, Kay R . 1995a Mol. Cell. Biol. 15: 704–710
Whitehead IP, Kirk H, Tognon C, Trigo-Gonzalez J, Kay R . 1995b J. Biol. Chem. 270: 18388–18395
Whitmarsh AJ, Yang S-H, Su MS, Sharrocks AD, Davis RJ . 1997 Mol. Cell Biol. 17: 2360–2371
Xu N, Bradley L, Ambdukar I, Gutkind JS . 1993 Proc. Natl. Acad. Sci. USA 90: 6741–6745
Young D, O'Neill K, Jessell T, Wigler M . 1988 Proc. Natl. Acad. Sci. USA 85: 5339–5342
Zohn IE, Symons M, Chrzanowska-Wodnicka M, Westwick JK, Der CJ . 1998a Mol. Cell Biol. 18: 1225–1235
Zohn IE, Campbell SL, Khosravi-Far R, Rossman KL, Der CJ . 1998b Oncogene 17: 1415–1438
Zohn IE, Klinger M, Karp X, Kirk H, Symons M, Chrazanowska-Wodnicka M, Der CJ, Kay R . 2000 Oncogene 19: 3866–3877
Acknowledgements
We thank Misha Rand for assistance in figure and manuscript preparation. This work was supported by Public Health Service grants CA42978, CA55008, CA63071 (CJ Der) and CA77493 (IP Whitehead) from the National Cancer Institute, and by a grant from the Medical Research Council of Canada (RJ Kay).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Martin, C., Mahon, G., Klinger, M. et al. The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways. Oncogene 20, 1953–1963 (2001). https://doi.org/10.1038/sj.onc.1204281
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204281
Keywords
This article is cited by
-
YAP and MRTF-A, transcriptional co-activators of RhoA-mediated gene expression, are critical for glioblastoma tumorigenicity
Oncogene (2018)
-
ALEX1, a novel tumor suppressor gene, inhibits gastric cancer metastasis via the PAR-1/Rho GTPase signaling pathway
Journal of Gastroenterology (2018)
-
Opportunities for therapeutic antibodies directed at G-protein-coupled receptors
Nature Reviews Drug Discovery (2017)
-
Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia
Oncogene (2017)
-
Platelet-targeted pharmacologic treatments as anti-cancer therapy
Cancer and Metastasis Reviews (2017)